Cargando…

Blood coagulation and the risk of atherothrombosis: a complex relationship

The principles of Virchov's triad appear to be operational in atherothrombosis or arterial thrombosis: local flow changes and particularly vacular wall damage are the main pathophysiological elements. Furthermore, alterations in arterial blood composition are also involved although the specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Spronk, Henri MH, van der Voort, Danielle, ten Cate, Hugo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC538274/
https://www.ncbi.nlm.nih.gov/pubmed/15574198
http://dx.doi.org/10.1186/1477-9560-2-12
_version_ 1782122046394728448
author Spronk, Henri MH
van der Voort, Danielle
ten Cate, Hugo
author_facet Spronk, Henri MH
van der Voort, Danielle
ten Cate, Hugo
author_sort Spronk, Henri MH
collection PubMed
description The principles of Virchov's triad appear to be operational in atherothrombosis or arterial thrombosis: local flow changes and particularly vacular wall damage are the main pathophysiological elements. Furthermore, alterations in arterial blood composition are also involved although the specific role and importance of blood coagulation is an ongoing matter of debate. In this review we provide support for the hypothesis that activated blood coagulation is an essential determinant of the risk of atherothrombotic complications. We distinguish two phases in atherosclerosis: In the first phase, atherosclerosis develops under influence of "classical" risk factors, i.e. both genetic and acquired forces. While fibrinogen/fibrin molecules participate in early plaque lesions, increased activity of systemic coagulation is of no major influence on the risk of arterial thrombosis, except in rare cases where a number of specific procoagulant forces collide. Despite the presence of tissue factor – factor VII complex it is unlikely that all fibrin in the atherosclerotic plaque is the direct result from local clotting activity. The dominant effect of coagulation in this phase is anticoagulant, i.e. thrombin enhances protein C activation through its binding to endothelial thrombomodulin. The second phase is characterized by advancing atherosclerosis, with greater impact of inflammation as indicated by an elevated level of plasma C-reactive protein, the result of increased production influenced by interleukin-6. Inflammation overwhelms protective anticoagulant forces, which in itself may have become less efficient due to down regulation of thrombomodulin and endothelial cell protein C receptor (EPCR) expression. In this phase, the inflammatory drive leads to recurrent induction of tissue factor and assembly of catalytic complexes on aggregated cells and on microparticles, maintaining a certain level of thrombin production and fibrin formation. In advanced atherosclerosis systemic and vascular wall driven coagulation becomes more important and elevated levels of D-dimer fragments should be interpreted as markers of this hypercoagulability.
format Text
id pubmed-538274
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-5382742004-12-19 Blood coagulation and the risk of atherothrombosis: a complex relationship Spronk, Henri MH van der Voort, Danielle ten Cate, Hugo Thromb J Review The principles of Virchov's triad appear to be operational in atherothrombosis or arterial thrombosis: local flow changes and particularly vacular wall damage are the main pathophysiological elements. Furthermore, alterations in arterial blood composition are also involved although the specific role and importance of blood coagulation is an ongoing matter of debate. In this review we provide support for the hypothesis that activated blood coagulation is an essential determinant of the risk of atherothrombotic complications. We distinguish two phases in atherosclerosis: In the first phase, atherosclerosis develops under influence of "classical" risk factors, i.e. both genetic and acquired forces. While fibrinogen/fibrin molecules participate in early plaque lesions, increased activity of systemic coagulation is of no major influence on the risk of arterial thrombosis, except in rare cases where a number of specific procoagulant forces collide. Despite the presence of tissue factor – factor VII complex it is unlikely that all fibrin in the atherosclerotic plaque is the direct result from local clotting activity. The dominant effect of coagulation in this phase is anticoagulant, i.e. thrombin enhances protein C activation through its binding to endothelial thrombomodulin. The second phase is characterized by advancing atherosclerosis, with greater impact of inflammation as indicated by an elevated level of plasma C-reactive protein, the result of increased production influenced by interleukin-6. Inflammation overwhelms protective anticoagulant forces, which in itself may have become less efficient due to down regulation of thrombomodulin and endothelial cell protein C receptor (EPCR) expression. In this phase, the inflammatory drive leads to recurrent induction of tissue factor and assembly of catalytic complexes on aggregated cells and on microparticles, maintaining a certain level of thrombin production and fibrin formation. In advanced atherosclerosis systemic and vascular wall driven coagulation becomes more important and elevated levels of D-dimer fragments should be interpreted as markers of this hypercoagulability. BioMed Central 2004-12-01 /pmc/articles/PMC538274/ /pubmed/15574198 http://dx.doi.org/10.1186/1477-9560-2-12 Text en Copyright © 2004 Spronk et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Spronk, Henri MH
van der Voort, Danielle
ten Cate, Hugo
Blood coagulation and the risk of atherothrombosis: a complex relationship
title Blood coagulation and the risk of atherothrombosis: a complex relationship
title_full Blood coagulation and the risk of atherothrombosis: a complex relationship
title_fullStr Blood coagulation and the risk of atherothrombosis: a complex relationship
title_full_unstemmed Blood coagulation and the risk of atherothrombosis: a complex relationship
title_short Blood coagulation and the risk of atherothrombosis: a complex relationship
title_sort blood coagulation and the risk of atherothrombosis: a complex relationship
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC538274/
https://www.ncbi.nlm.nih.gov/pubmed/15574198
http://dx.doi.org/10.1186/1477-9560-2-12
work_keys_str_mv AT spronkhenrimh bloodcoagulationandtheriskofatherothrombosisacomplexrelationship
AT vandervoortdanielle bloodcoagulationandtheriskofatherothrombosisacomplexrelationship
AT tencatehugo bloodcoagulationandtheriskofatherothrombosisacomplexrelationship